A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.
about
Maintaining fluoroquinolone class efficacy: review of influencing factors.Gatifloxacin, an advanced 8-methoxy fluoroquinolone.Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistanceEfficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study.Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.Pharmacodynamics of moxifloxacin against Streptococcus pyogenes in an in vitro kinetic model.The spectrum of acute bronchitis. Using baseline factors to guide empirical therapy.Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in micePharmacokinetic study on pradofloxacin in the dog - comparison of serum analysis, ultrafiltration and tissue sampling after oral administrationIntravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study.Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumonia.Penetration of moxifloxacin into the human aqueous humour after oral administration.Moxifloxacin in respiratory tract infections.Genomics of IncP-1 antibiotic resistance plasmids isolated from wastewater treatment plants provides evidence for a widely accessible drug resistance gene pool.Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.10 years' experience with the pneumococcal quinolone moxifloxacin.Gemifloxacin: a new fluoroquinolone.Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate.The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens.Intravitreal clearance of moxifloxacin.Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study.Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia.A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.Levofloxacin failure in a patient with pneumococcal pneumonia.Comparative activity of pradofloxacin and marbofloxacin against coagulase-positive staphylococci in a pharmacokinetic-pharmacodynamic model based on canine pharmacokinetics.Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia.Vitreous and aqueous penetration of orally administered moxifloxacin in humans.Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities.Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.Moxifloxacin: a respiratory fluoroquinolone
P2860
Q30310427-43E8D003-7080-41EF-8296-B1E4655EC494Q31975922-41FD5199-851C-435C-8BDF-9C32A1FF754EQ33595145-E29E5904-167D-4CD0-A1C9-5FC889876BBFQ33812856-E44D425F-3E36-4856-A79E-D68819872616Q33836612-968FA04D-ADC5-4A0B-8B1E-22D7DFB7D18DQ34108406-C4C2AF0F-B66B-449B-82A9-D3CC14551EB2Q34197827-433848F2-DC7A-4BB9-9F6D-ABE08893DBE6Q34240856-6FC5786D-E8BD-4119-ADE5-FB303BF9EF3EQ34352075-FA4EB7C6-45FA-4C38-8865-6EB51E6C6D02Q34587450-9D70CCD9-1A7A-406F-9535-F85FF9ACB346Q35024966-24745C8A-796B-46B5-9BE1-7238A51A9415Q35168927-24543F75-5574-47D0-A089-F631F6A2DD81Q35593192-2CCE1F1D-59A3-48DB-9B63-7AA95CC59320Q36066098-EA58411C-61CA-4DD2-A484-705F1BB773FFQ36841958-70B463B0-F86E-4737-AF92-225E1B220EF1Q37071001-E3F7791D-9F11-465C-B2E8-96DDEB9B9AEBQ37568953-D0A3DE65-178B-49A6-BA9E-C82D24186AA3Q37577369-CC5C2EA7-9A27-4D97-A170-810BD246D319Q37579919-57DCEF57-1FD6-42AE-8677-C4417CA4EFF6Q37867123-D79EA44A-D528-4AA0-A21A-8F46184CB592Q38703330-59A65CFB-E4A0-4594-A930-E4EDBEB0E5FFQ39475328-90A20234-460D-4F06-B75C-D6AF152BBFAAQ39657998-B858F312-43E1-44B9-8E35-01945A45EE45Q40667218-BFC8F5A0-7A83-48D1-8F0F-4FCD65FEC545Q40732558-6E2A0876-5ABD-4056-BE63-FF1FFED74322Q41098625-07D072EE-BECE-4DDB-8233-0A95C3A52A7DQ41838062-2AFFFD82-9619-4434-9C1B-87BE05032B33Q43103062-73EAD4B1-CBC0-45BC-87A8-A9E4272C2C29Q43181838-02FF80E2-894F-4D39-AE55-8E6939BE9EB8Q43264842-754614EC-C68A-4F77-AB9D-4E5F946EFE24Q43642324-2F62E31C-188B-4EDC-B887-24F1E06B1D44Q43803237-2D190C98-956E-4A41-96F7-23BDA9EFA7F4Q43920524-5BCF7360-2AE0-4C80-AEA7-9B4AC3A926E1Q44550456-8DB03DFE-D619-42EA-A991-05C7FEE797F8Q44839668-EBBD7298-A108-44C5-AD97-0B1DBEC0FB6CQ47101582-968A75D8-76AA-4CAA-9E81-5DF4CF7967ACQ48109300-B309E2AA-6B36-4C2A-83A5-4714C56B0493Q57778170-3CD6D81C-6379-4442-9FDF-876170067D7A
P2860
A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A review of the comparative in ...... e new respiratory quinolones'.
@ast
A review of the comparative in ...... e new respiratory quinolones'.
@en
type
label
A review of the comparative in ...... e new respiratory quinolones'.
@ast
A review of the comparative in ...... e new respiratory quinolones'.
@en
prefLabel
A review of the comparative in ...... e new respiratory quinolones'.
@ast
A review of the comparative in ...... e new respiratory quinolones'.
@en
P356
P1476
A review of the comparative in ...... e new respiratory quinolones'.
@en
P2093
Blondeau JM
P356
10.1093/JAC/43.SUPPL_2.1
P407
P478
43 Suppl B
P577
1999-05-01T00:00:00Z